Company to Halt Sales of Antidepressant in U.S.
- Share via
From Times Wire Reports
Bristol-Myers Squibb will stop selling its controversial antidepressant Serzone in the United States starting next month, a company spokesman said.
Serzone has been linked to dozens of cases of liver failure and injury, including at least 20 deaths.
The drug, the subject of several lawsuits, is one of 17 to be discontinued due to poor sales and growing competition, said Robert Hutchison, a spokesman for Bristol-Myers.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
